🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Brittany Resnick

Royal Devon & Exeter NHS Foundation Trust

ORCID: 0000-0001-6293-777X

Also affiliated with NIHR Exeter Clinical Research Facility

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial”.

Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Diabetes & Endocrinology(2021)10.1016/s2213-8587(21)00139-x

N/A

4.6DataRank · unranked

135 citations

Brian N. Bundy, Ele Ferrannini, Noha Lim, Lori Blanchfield, Linda A. DiMeglio +60 more

Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency.

PubMed(2024)10.1084/jem.20231704

N/A

0.452DataRank · unranked

11 citations

Masato Ogishi, Clara Domingo‐Vila, Elisa De Franco, Matthew N. Wakeling, Zineb Imane +22 more

Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes

Diabetologia(2022)10.1007/s00125-022-05697-3

N/A

0DataRank · unranked

3 citations

William Hagopian, Bart O. Roep, Kashyap A. Patel, Brittany Resnick, Rebecca Dobbs +8 more